<DOC>
	<DOCNO>NCT01940575</DOCNO>
	<brief_summary>- Study design : Multi-center , randomize , double-masked ( Unblinded treating investigator ) , intra-individual comparison clinical trial</brief_summary>
	<brief_title>Efficacy Safety Study SkinPlus-Hyal速 Nasolabial Fold</brief_title>
	<detailed_description>- Subjects : Adults nasolabial fold - Investigational Devices : Study Device : SkinPlus-Hyal速 Comparator Device : Restylane速 - Procedure Before Treatment : The subject 's eligibility ( inclusion/exclusion criterion ) assess , WSRS his/her nasolabial fold wil evaluate Investigator Treatment : The Injector administer eligible subject Study Device Comparator Device respectively leave right nasolabial fold randomize manner . Post-Treatment : All subject visit hospital 2 , 8 , 16 , 24 week since day administration , take picture Nasolabial fold area undergo efficacy safety evaluation visit . The Photographic evaluator evaluate efficacy</detailed_description>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1 . Men woman age 20 2 . Subjects want correct his/her nasolabial fold point 3 4 WSRS nasolabial fold visually symmetric 3 . Subjects voluntarily decide participation study sign informed consent 4 . Subjects agree contraception 1 . Subjects anaphylaxis severe combine allergy , allergy hyaluronic acid 2 . Subjects eczema , infection , psoriasis , sclerosis , acne face 3 . Subjects skin disorder NLF area 4 . Subjects permanent implant dermal augmentation NLF area 5 . Subjects history keloid formation hypertrophic scar 6 . Subjects participate clinical trial within 3 month screen date 7 . Female subject childbearing potential disagreed medically acceptable contraception ( e.g. , condom , oral contraceptive continue least 3 month , injectable insertable contraceptive , intrauterine contraceptive device ) trial 8 . Subjects Drug abuser alcoholism 9 . Subjects previous treatment Botox within 6 month screen date 10 . Subjects previous treatment wrinkle RetinA within 1 month screen date 11 . Subjects previous treatment tissue restorative biomaterials within 18 month screen date 12 . Patients eligible study medical discretion Principal Investigator Subinvestigator 13 . Subjects antigen HIV typeB Hepatitis 14 . Subjects anticoagulant therapy within 2 week screen date 15 . Patients eligible study medical discretion Principal Investigator Subinvestigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Tissue restorative biomaterial</keyword>
	<keyword>Hyaluronic acid</keyword>
	<keyword>Restylane速</keyword>
	<keyword>Wrinkle Severity Rating Scale ( WSRS )</keyword>
	<keyword>Global Aesthetic Improvement Scale ( GAIS )</keyword>
	<keyword>Nasolabial fold ( NLF )</keyword>
</DOC>